Companies with a Future performance score of at least 3, ordered by Future performance score.
Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes.
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops, markets, and commercializes treatments for the treatment of autoimmune diseases, viral infections, and cancer in France.
Valbiotis SA develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.
Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products.
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases.
Lysogene S.A. engages in the research and clinical development of gene therapy for neurodegenerative disorders.
Oncodesign Société Anonyme, a biotechnology company, conducts research and development work on new therapeutic and diagnostic tools along with pharmaceutical firms, biotech companies, public research institutions, and investment groups.
Pharnext SA, a clinical-stage biopharmaceutical company, develops therapeutics for severe orphan and common neurodegenerative diseases in France.
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide.
Ipsen S.A. operates as a biopharmaceutical company worldwide.
Virbac SA produces and sells medicines and vaccines for companion and food-producing animals in France and internationally.